scispace - formally typeset
J

Jeffrey A. Gold

Researcher at Oregon Health & Science University

Publications -  76
Citations -  2947

Jeffrey A. Gold is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Patient safety & Innate immune system. The author has an hindex of 25, co-authored 74 publications receiving 2492 citations. Previous affiliations of Jeffrey A. Gold include Columbia University & New York University.

Papers
More filters
Journal ArticleDOI

Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense

TL;DR: It is shown that lipopolysaccharide from Gram-negative bacteria activates interleukin-5 (IL-5)- or interferon-γ–primed eosinophils to release mitochondrial DNA in a reactive oxygen species–dependent manner, but independent of eosInophil death, suggesting a previously undescribed mechanism of eOSinophil-mediated innate immune responses that might be crucial for maintaining the intestinal barrier function after inflammation-associated epithelial cell damage
Journal ArticleDOI

A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens

TL;DR: New guidelines emphasizing escalating bolus doses of diazepam, and barbiturates if necessary, significantly reduced the need for mechanical ventilation and showed trends toward reductions in ICU length of stay and nosocomial infections.
Journal ArticleDOI

Alcohol withdrawal syndromes in the intensive care unit.

TL;DR: This article reviews the pathophysiology, diagnosis, and treatment of alcohol withdrawal syndromes in the intensive care unit as well as the literature on the optimal pharmacologic strategies for treatment of Alcohol withdrawal syndrome in the critically ill.
Journal ArticleDOI

Differential Role for CD80 and CD86 in the Regulation of the Innate Immune Response in Murine Polymicrobial Sepsis

TL;DR: A differential role for CD80 and CD86 in regulation of inflammation in the innate immune response to sepsis is described, suggesting a divergent role for these receptors.
Journal ArticleDOI

CD40 and CD80/86 Act Synergistically to Regulate Inflammation and Mortality in Polymicrobial Sepsis

TL;DR: These data demonstrate a central role for CD40 and CD80/86 in the innate immune response and suggest that combined inhibition of CD 40 and CD 80/86 may improve mortality in sepsis.